Efficacy of Clopidogrel and Clinical Outcome When Clopidogrel Is Coadministered With Atorvastatin and Lansoprazole
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference36 articles.
1. 2011 ACCFAHASCAI Guideline for Percutaneous Coronary Intervention: Executive Summary. A Report of the American College of Cardiology FoundationAmerican Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.;Levine;J Am Coll Cardiol,2011
2. Aspirin and clopidogrel resistance.;Fitzgerald;Hematology Am Soc Hematol Educ Program,2007
3. Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study.;Gurbel;J Am Coll Cardiol,2005
4. Consensus and future directions on the definition of high on treatment platelet reactivity to adenosine diphosphate.;Bonello;J Am Coll Cardiol,2010
5. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.;Matetzky;Circulation,2004
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effectiveness of lipid-lowering therapy on mortality and major adverse cardiovascular event outcomes in patients undergoing percutaneous coronary intervention: a network meta-analysis of randomised controlled trials;BMJ Open;2023-11
2. Atorvastatin Effect on Clopidogrel Efficacy in Patients with Peripheral Artery Disease;Annals of Vascular Surgery;2023-09
3. Bed Allocation Optimization Based on Survival Analysis, Treatment Trajectory and Costs Estimations;IEEE Access;2023
4. The Overriding of Computerized Physician Order Entry (CPOE) Drug Safety Alerts Fired by the Clinical Decision Support (CDS) Tool: Evaluation of Appropriate Responses and Alert Fatigue Solutions;Cureus;2022-11-15
5. Efficacy and Safety of Proton Pump Inhibitors in Patients With Coronary Artery Diseases Receiving Oral Antiplatelet Agents and/or Anticoagulants: A Systematic Review and Meta-Analysis;Journal of Cardiovascular Pharmacology;2022-05-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3